Karuna Therapeutics Inc. (KRTX) Surges After Trial Meets Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. SPY
3. AAPL
4. XPEV
5. USO
6. BMO
7. VEEV
8. DKS
9. MU
10. SPCX

Go back to Karuna Therapeutics Inc. (KRTX) Surges After Trial Meets Primary Endpoint

Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia

August 8, 2022 7:03 AM EDT

Trial met primary endpoint, with KarXT demonstrating a statistically significant 9.6-point reduction in PANSS Total Score compared to placebo at Week 5 (p... More